SCHEDULE 13G

Company

Sarepta Therapeutics, Inc.

Filed

December 27, 1999

Accession Number

0000912057-99-010563

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →